Sichuan Hebang Biotechnology Balance Sheet Health
Financial Health criteria checks 4/6
Sichuan Hebang Biotechnology has a total shareholder equity of CN¥19.7B and total debt of CN¥3.0B, which brings its debt-to-equity ratio to 15%. Its total assets and total liabilities are CN¥25.6B and CN¥6.0B respectively. Sichuan Hebang Biotechnology's EBIT is CN¥994.6M making its interest coverage ratio -9.8. It has cash and short-term investments of CN¥2.8B.
Key information
15.0%
Debt to equity ratio
CN¥2.96b
Debt
| Interest coverage ratio | -9.8x |
| Cash | CN¥2.78b |
| Equity | CN¥19.67b |
| Total liabilities | CN¥5.96b |
| Total assets | CN¥25.64b |
Financial Position Analysis
Short Term Liabilities: 603077's short term assets (CN¥10.8B) exceed its short term liabilities (CN¥5.1B).
Long Term Liabilities: 603077's short term assets (CN¥10.8B) exceed its long term liabilities (CN¥874.3M).
Debt to Equity History and Analysis
Debt Level: 603077's net debt to equity ratio (0.9%) is considered satisfactory.
Reducing Debt: 603077's debt to equity ratio has increased from 11.9% to 15% over the past 5 years.
Debt Coverage: 603077's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603077 earns more interest than it pays, so coverage of interest payments is not a concern.